ClinicalTrials.Veeva

Menu

The Efficacy and Safety of Dezocine Pretreatment for Pain Relief in Acne Scar Treatment of Fractional CO2 Laser

A

Air Force Military Medical University of People's Liberation Army

Status and phase

Enrolling
Phase 4

Conditions

Acne Atrophica

Treatments

Drug: Dezocine
Device: Fractional CO2 laser

Study type

Interventional

Funder types

Other

Identifiers

NCT05861063
XijingH-PF-20232019-F-1

Details and patient eligibility

About

The Efficacy and Safety of Dezocine Pretreatment for Pain Relief in Acne Scar Treatment of Fractional CO2 Laser

Enrollment

105 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age: 18-60 years old, regardless of gender;
  2. Clinical diagnosis of atrophic acne scars;
  3. Planning to undergo ultra-pulsed CO2 lattice laser therapy;
  4. The patient agrees to participate in this experiment and signs an informed consent form

Exclusion criteria

  1. Those who take sedative drugs for a long time;

  2. Patients with sleep apnea syndrome, previous history of hypertension, and blood pressure greater than 160/100mmHg

  3. People with severe heart and lung diseases, liver and kidney diseases, psychosis, pregnancy, and communication disorders;

  4. Persons who are known to be allergic to the main drug or any of the excipients in Dezocine injection;

  5. Increased intracranial pressure or head injury;

  6. Acute and chronic alcoholism;

  7. People with hypotension, hypothyroidism, acute episodes of asthma, and epilepsy

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

105 participants in 3 patient groups, including a placebo group

control group
Placebo Comparator group
Description:
The patients were divided into 3 groups based on different dosages of Dezocine injection, with 35 patients in each group: Group 1: Dezocine low-dose group, Group 2: Dezocine high-dose group; Group 3: Blank control group (normal saline).
Treatment:
Device: Fractional CO2 laser
Dezocine low dose group
Experimental group
Description:
The patients were divided into 3 groups based on different dosages of Dezocine injection, with 35 patients in each group: Group 1: Dezocine low-dose group, Group 2: Dezocine high-dose group; Group 3: Blank control group (normal saline).
Treatment:
Drug: Dezocine
Device: Fractional CO2 laser
Dezocine high dose group
Experimental group
Description:
The patients were divided into 3 groups based on different dosages of Dezocine injection, with 35 patients in each group: Group 1: Dezocine low-dose group, Group 2: Dezocine high-dose group; Group 3: Blank control group (normal saline).
Treatment:
Drug: Dezocine
Device: Fractional CO2 laser

Trial contacts and locations

1

Loading...

Central trial contact

Chen Yu, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems